APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM NEW
Total 13F shares
963,250
Share change
+96,141
Total reported value
$2,271,536
Price per share
$2.32
Number of holders
26
Value change
+$237,695
Number of buys
13
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q4 2022

As of 31 Dec 2022, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 963,250 shares. The largest 10 holders included VANGUARD GROUP INC, CANTOR FITZGERALD, L. P., Schonfeld Strategic Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, CITADEL ADVISORS LLC, Bank of New York Mellon Corp, and NORTHERN TRUST CORP. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.